BCR and prostate cancer: Assessment of mGSTP1 as a proxy for tumour load in biopsy cores targeted to regions of the prostate where positive margins commonly occur (apex or base) could also provide pre‐operative prognostication of margin status, itself known to be a highly prognostic clinical variable of BCR in prostate cancer.31